A targeted therapy improves disease-free survival when given to people with certain hereditary mutations after breast cancer surgery, and the Food and Drug Administration approves a new lung cancer treatment targeting a mutated form of the KRAS protein.

by Kevin McLaughlin

A study finds that many people with solid tumors mount an antibody response following COVID-19 vaccination, and the Food and Drug Administration approves the first targeted therapy for a rare lung cancer subtype.

by Kate Yandell

The U.S. Preventive Services Task Force lowers its recommended age to begin colorectal cancer screening to 45, and a major multiple myeloma study begins in Iceland.

by Bradley Jones

Researchers report disappointing results about ovarian cancer screening, and cancer patients with impaired immune function feel uncertain about protection offered by COVID-19 vaccination.

by Marci A. Landsmann

A Food and Drug Administration panel recommends withdrawing approvals for two treatment indications for immunotherapy drugs, and the U.S. Preventive Services Task Force recommend against vitamin E and beta-carotene for cancer prevention.

by Kevin McLaughlin

President Biden resurfaces a proposal for a new health care agency, and the Food and Drug Administration approves a treatment for large B-cell lymphoma.

by Bradley Jones

Anti-racism activist and historian Ibram X. Kendi opens up about his stage IV colon cancer treatment, and the FDA approves an immunotherapy drug for endometrial cancer

by Marci A. Landsmann

Studies presented at the AACR Annual Meeting 2021 shed light on treatment of a variety of cancers, and articles discuss the risks of COVID-19 for people who have been vaccinated but are immunocompromised.

by Kate Yandell

A nationwide campaign encourages Americans to get their cancer screenings, and a study reports improved outcomes for patients taking oral cancer drugs when they have professional oversight.

by Kevin McLaughlin

A study indicates that people are delaying medical care until they are eligible for Medicare, leading to missed cancers, and the Food and Drug Administration approves the first CAR-T cell therapy for multiple myeloma.

by Kate Yandell